Earnings History Data for Artelo Biosciences (ARTL) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Artelo Biosciences
Artelo Biosciences Inc. is a biopharmaceutical company. It is engaged in development and commercialization of proprietary therapeutics targeting the endocannabinoid system. The company's product pipeline consists of ART27.13, ART12.11 and ART26.12 which are in clinical stage. Artelo Biosciences Inc. is based in La Jolla, CA.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25-03-2024 | PM | ARTL | Artelo Biosciences | 4.00 | -0.99 | -0.29 | 0.00 | Artelo Biosciences GAAP EPS of -$3.14 misses by $0.58 [3/25/2024 9:05 AM] |
1.51 | -0.01 (-0.94%) |
0.0 | 0.0 (0.00%) |
1.15 - 2.98 | 4,883 | 20,000 | 0 | ||
| 13-11-2023 | PM | ARTL | Artelo Biosciences | 4.00 | -0.83 | -0.70 | 0.00 | Artelo Biosciences GAAP EPS of -$0.83 misses by $0.18 [11/13/2023 2:40 PM] |
1.25 | -0.02 (-1.57%) |
1.21 | -0.06 (-4.72%) |
1.16 - 3.50 | 25,927 | 20,000 | 1,013 | ||
| 10-08-2023 | PM | ARTL | Artelo Biosciences | 6.00 | -0.56 | -0.93 | 0.00 | Artelo Biosciences Q2 GAAP EPS of -$0.56 [8/10/2023 10:44 AM] |
1.98 | 0.01 (0.50%) |
0.0 | 0.0 (0.00%) |
1.39 - 7.20 | 10,857 | 10,000 | 0 | ||
| 11-05-2023 | PM | 8:00 AM ET (May 11) |
ARTL | Artelo Biosciences | 5.00 | -0.76 | -0.99 | 0.00 | Artelo Biosciences GAAP EPS of -$0.76 [5/11/2023 9:40 AM] |
1.69 | -0.02 (-1.41%) |
0.0 | 0.0 (0.00%) |
1.39 - 7.20 | 4,343 | 30,000 | 0 | |
| 31-03-2023 | PM | 8:00 AM ET (Mar 31) |
ARTL | Artelo Biosciences | 6.00 | -1.18 | -0.87 | 0.00 | Artelo Biosciences GAAP EPS of -$3.56 [3/31/2023 8:49 AM] |
2.29 | 0.14 (6.51%) |
0.0 | 0.0 (0.00%) |
2.01 - 11.07 | 28,212 | 20,000 | 0 | |
| 08-11-2022 | PM | ARTL | Artelo Biosciences | 8.00 | -0.82 | -0.90 | 0.00 | Artelo Biosciences GAAP EPS of -$0.82 beats by $0.09 [11/8/2022 9:08 AM] |
2.80 | 0.06 (2.19%) |
0.0 | 0.0 (0.00%) |
2.67 - 16.50 | 12,419 | 10,000 | 0 | ||
| 12-01-2022 | PM | ARTL | Artelo Biosciences | 19.00 | -0.08 | -0.06 | 0.00 | Artelo Biosciences GAAP EPS of -$0.08 [1/12/2022 9:00 AM] |
0.4739 | 0.0 (0.62%) |
0.46 | -0.01 (-1.80%) |
0.44 - 3.67 | 724,351 | 780,000 | 31,623 | ||
|
||||||||||||||||||
| 29-11-2021 | PM | 8:30 AM ET (Nov 29) |
ARTL | Artelo Biosciences | 18.00 | -0.07 | -0.10 | 0.00 | Artelo Biosciences EPS beats by $0.03 [11/29/2021 8:37 AM] |
0.6680 | -0.04 (-6.03%) |
0.73 | 0.02 (2.69%) |
0.54 - 3.67 | 1,585,055 | 3,340,000 | 242,325 | |
| 13-04-2021 | PM | ARTL | Artelo Biosciences, Inc. | 23.88 | -0.11 | 0.00 | -0.40 | Artelo Biosciences EPS beats by $0.01 [4/13/2021 9:08 AM] |
1.44 | 0.06 (4.35%) |
1.45 | 0.07 (5.07%) |
0.45 - 3.67 | 772,962 | 710,000 | 23,613 | ||
|
||||||||||||||||||